Received May 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | TC47K | — |
wrong vaccine administered; a patient received a fourth dose of Pediarix; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 1-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number TC47K, expiry date 29-MAR-2026) for prophylaxis. Co-suspect products included DTPa (Infanrix) for prophylaxis. On an unknown date, the patient received Pediarix and did not receive Infanrix. On an unknown date, an unknown time after receiving Pediarix and not applicable after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: wrong vaccine administered) and extra dose administered (Verbatim: a patient received a fourth dose of Pediarix). The outcome of the wrong vaccine administered and extra dose administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-MAY-2025 The registered nurse reported a patient received a fourth dose of Pediarix instead of a dose of Infanrix which led to wrong vaccine administered and extra dose administration.